Compare SCNI & IPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCNI | IPST |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | Israel | United States |
| Employees | N/A | 21 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 1.8M |
| IPO Year | 2014 | N/A |
| Metric | SCNI | IPST |
|---|---|---|
| Price | $0.26 | $2.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $164.00 |
| AVG Volume (30 Days) | ★ 289.9K | 22.2K |
| Earning Date | 05-11-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $70.16 |
| Revenue Next Year | N/A | $60.33 |
| P/E Ratio | ★ N/A | $0.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $0.24 |
| 52 Week High | $3.47 | $15.08 |
| Indicator | SCNI | IPST |
|---|---|---|
| Relative Strength Index (RSI) | 33.39 | 38.40 |
| Support Level | N/A | $0.43 |
| Resistance Level | $1.05 | $3.95 |
| Average True Range (ATR) | 0.03 | 0.30 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 10.51 | 27.03 |
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.